Clinical Trial Update: LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study [Phase 1, Phase 2]

View source ↗

Summary

A single-arm Phase 1/2 trial evaluating low-dose radiotherapy in combination with pucotenlimab and standard therapy for advanced pancreatic cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Low-Dose Radiotherapy (LDRT) (low-dose radiotherapy)
• Pucotenlimab

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Pancreatic Cancer, PD-L1 | Phase 1, Phase 2 | Status: RECRUITING